These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2793642)

  • 1. In-vitro evaluation of antibiotic combinations against Campylobacter fetus.
    Goossens H; Coignau H; Vlaes L; Butzler JP
    J Antimicrob Chemother; 1989 Aug; 24(2):195-201. PubMed ID: 2793642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of antibiotics for treatment of meningitis caused by Campylobacter fetus subspecies fetus.
    Morooka T; Oda T; Shigeoka H
    Pediatr Infect Dis J; 1989 Sep; 8(9):653-4. PubMed ID: 2797963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibiotic resistance of Campylobacter and its epidemiologic significance].
    Aleksandrova NZ; Minaev VI; Gorelov AV
    Antibiot Khimioter; 1990 Mar; 35(3):34-6. PubMed ID: 2360853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and antimicrobial susceptibility of Campylobacter coli and Campylobacter jejuni from slaughter hogs.
    Hariharan H; Wright T; Long JR
    Microbiologica; 1990 Jan; 13(1):1-6. PubMed ID: 2308529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A man with Campylobacter endocarditis, treatable as Campylobacter fetus following identification].
    Ang CW; Endtz HP; Kuijper EJ
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1384; author reply 1384-5. PubMed ID: 12892017
    [No Abstract]   [Full Text] [Related]  

  • 6. Imipenem-resistant Campylobacter fetus bloodstream infection.
    Mosca A; Del Gaudio T; Miragliotta G
    J Chemother; 2010 Apr; 22(2):142. PubMed ID: 20435578
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Campylobacter fetus subsp. fetus isolated from blood and synovial fluid.
    Kwon SY; Cho DH; Lee SY; Lee K; Chong Y
    Yonsei Med J; 1994 Sep; 35(3):314-9. PubMed ID: 7975740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Campylobacter fetus subsp. jejuni, isolated from patients in Jakarta, Indonesia to ten antimicrobial agents.
    Ringertz S; Rockhill RC; Ringertz O
    J Antimicrob Chemother; 1981 Oct; 8(4):333-6. PubMed ID: 7298551
    [No Abstract]   [Full Text] [Related]  

  • 9. Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.
    Michel J; Rogol M; Dickman D
    Antimicrob Agents Chemother; 1983 May; 23(5):796-7. PubMed ID: 6870228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Four cases of infection by Campylobacter fetus ssp. fetus].
    Yamazaki E; Kitano A; Mizuoka K
    Rinsho Byori; 1986 Jun; 34(6):716-22. PubMed ID: 3747211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Campylobacter fetus jejuni: incidence in diarrhea and antimicrobial sensitivity].
    López-Brea M; Molina Jiménez D; Granda Díez P
    Rev Sanid Hig Publica (Madr); 1980; 54(1-2):69-78. PubMed ID: 7348345
    [No Abstract]   [Full Text] [Related]  

  • 12. Campylobacter enteritis in Sri Lanka.
    Palasuntheram C; Wijesekera DS
    Ceylon Med J; 1982 Jun; 27(2):80-4. PubMed ID: 7160007
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ; Ibrahim ME; Gill KP
    Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Campylobacteriosis in humans caused by subspecies intestinalis and fetus. Six new diseases (author's transl)].
    Ullmann U; Langmaack H; Blasius C
    Infection; 1982; 10 Suppl 2():S64-6. PubMed ID: 7107019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.
    Altwegg M; Burnens A; Zollinger-Iten J; Penner JL
    J Clin Microbiol; 1987 Sep; 25(9):1807-8. PubMed ID: 3654954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter fetus subspecies fetus meningitis with chronic alcoholism and diabetes mellitus.
    Kato H; Wakasugi H; Mukuta T; Furukawa M; Yokota M; Yamada Y; Funakoshi A; Abe M
    Jpn J Med; 1990; 29(5):542-4. PubMed ID: 2089181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic cutoff values to separate wild-type from non-wild-type Campylobacter fetus to ciprofloxacin.
    Bénéjat L; Sifré E; Domingues Martins C; Ducournau A; Buissonnière A; Bessède E; Mégraud F; Lehours P
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):164-167. PubMed ID: 29884563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Campylobacter jejuni to rokitamycin.
    Miyake Y; Okada M; Sasaki M; Nagasaka N; Suginaka H
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1440-1. PubMed ID: 2386373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media.
    Ng LK; Stiles ME; Taylor DE
    J Clin Microbiol; 1985 Oct; 22(4):510-4. PubMed ID: 4077962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada.
    Taylor DE; Chang N; Garner RS; Sherburne R; Mueller L
    Can J Microbiol; 1986 Jan; 32(1):28-32. PubMed ID: 3008970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.